Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 7.68% |
| 3 | Healthcare | 6.5% |
| 4 | Industrials | 5.87% |
| 5 | Consumer Discretionary | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5276
PUT
LPL Financial
LPLA
$28.3B
| $266K | ﹤0.01% |
800
-4,200
| -84% | -$1.52M |
|
5277
Envela
ELA
$563M
| $266K | ﹤0.01% |
34,026
+12,614
| +59% | +$85.3K |
|
|
FPF
5278
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.07B
| $266K | ﹤0.01% |
+13,866
| New | +$264K |
|
5279
First Busey Corp
BUSE
$2.57B
| $265K | ﹤0.01% |
11,445
-489,100
| -98% | -$11.7M |
|
5280
Nu Skin
NUS
$252M
| $265K | ﹤0.01% |
21,710
-67,507
| -76% | -$709K |
|
5281
Ardmore Shipping
ASC
$710M
| $265K | ﹤0.01% |
22,290
-36,006
| -62% | -$403K |
|
5282
CALL
Aldeyra Therapeutics
ALDX
$92.9M
| $264K | ﹤0.01% |
+50,600
| New | +$264K |
|
|
TUYA
5283
Tuya Inc
TUYA
$1.03B
| $264K | ﹤0.01% |
106,934
-134,347
| -56% | -$336K |
|
|
NNNN
5284
Anbio Biotechnology
NNNN
$435M
| $264K | ﹤0.01% |
+7,080
| New | +$318K |
|
5285
Petco
WOOF
$797M
| $263K | ﹤0.01% |
68,071
-115,202
| -63% | -$386K |
|
5286
CALL
Vodafone
VOD
$36.3B
| $263K | ﹤0.01% |
22,700
| – | – |
|
5287
Gilat Satellite Networks
GILT
$834M
| $263K | ﹤0.01% |
20,215
+5,852
| +41% | +$53.7K |
|
5288
Innovative Solutions & Support
ISSC
$327M
| $263K | ﹤0.01% |
21,018
-37,492
| -64% | -$523K |
|
|
HPE.PRC
5289
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$3.74B
| $262K | ﹤0.01% |
191,800
+116,600
| +155% | +$7.32M |
|
|
RTACU
5290
Renatus Tactical Acquisition Corp I Unit
RTACU
$187M
| $262K | ﹤0.01% |
22,860
-143,904
| -86% | -$1.72M |
|
5291
Vuzix
VUZI
$194M
| $261K | ﹤0.01% |
83,540
-885,620
| -91% | -$2.09M |
|
5292
PUT
Entergy
ETR
$50.2B
| $261K | ﹤0.01% |
2,800
-36,800
| -93% | -$3.24M |
|
|
UHGWW
5293
CALL
DELISTED
United Homes Group Warrant
UHGWW
| $260K | ﹤0.01% |
140,711
-5,648
| -4% | -$7.8K |
|
5294
OmniAb
OABI
$287M
| $260K | ﹤0.01% |
285,801
-364,515
| -56% | -$666K |
|
5295
abrdn Physical Palladium Shares ETF
PALL
$618M
| $260K | ﹤0.01% |
+11,365
| New | +$243K |
|
5296
Cartesian Therapeutics
RNAC
$229M
| $259K | ﹤0.01% |
+25,357
| New | +$285K |
|
5297
Microbot Medical
MBOT
$116M
| $259K | ﹤0.01% |
+84,782
| New | +$264K |
|
5298
Accuray
ARAY
$32M
| $258K | ﹤0.01% |
154,415
-295,287
| -66% | -$437K |
|
5299
CALL
Factset
FDS
$9.36B
| $258K | ﹤0.01% |
+900
| New | +$344K |
|
|
SGMO
5300
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $257K | ﹤0.01% |
380,976
+16,829
| +5% | +$9.07K |
|
Similar funds
Millennium Management's Q3 2025 Portfolio in Review
As of Q3 2025, Millennium Management held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Millennium Management added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Millennium Management's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Millennium Management fully exited Hess in Q3 2025, selling an estimated $478M.
- Millennium Management's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Millennium Management opened 800 new positions and closed 633 in Q3 2025.
- Millennium Management's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.